Table 1.
Pharmacological and comorbidity data for all subjects at baseline (n=50).
Prescribed drug
Frequency in initial 50 volunteers (%)
Beta Blocker
7 (14%)
Statin
29 (58%)
ACE Inhibitor
22 (44%)
Ca
+
channel blocker
10 (20%)
PPI
11 (22%)
Diuretic
12 (24%)
Inotrope
4 (8%)
Biguinide
11 (22%)
Anteplatelet therapy
37 (74%)
Sulphonylureas
5 (10%)
Insulin
4 (8%)
Comorbidities/Previous interventions
Diabetes
5 (10%)
Current coronary artery disease
7 (14%)
Hypertension (controlled)
22 (44%)
Previous PTCA (>12 months)
1 (2%)
Previous CABG (>12 months)
2 (4%)
Previous MI
1 (2%)
CABG - Coronary artery bypass graft
PTCA - Percutaneous transluminal coronary angioplasty